Company / SG&A per Share
Outlook Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.25
FY2025
5-year range
$0.33 / $1.58
FY2021-FY2025
Trend
+282.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +282% YoY in FY2025, a notable deviation from the 5-year average annual change of +57%.
Based on SEC 10-K filings.
1.25 in FY2025 with a 5-year CAGR of +30.8%.
Improved from $1.58 to $1.25 over the past 6 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +30.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 282.4% year-over-year.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.25 | +282.4% |
| FY2020 | $0.33 | -79.2% |
| FY2019 | $1.58 | +147.4% |
| FY2018 | $0.64 | -32.6% |
| FY2017 | $0.95 | -30.9% |
| FY2016 | $1.37 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026